Articles related to CRITICAL CARE

Emerging data suggest that lactated Ringer’s is associated with improved health outcomes and may be superior to normal saline in acute pancreatitis management.

Neffy®, an FDA-approved intranasal epinephrine spray, demonstrates bioequivalence to injectable epinephrine for anaphylaxis treatment in patients weighing ≥30kg, potentially reducing barriers to rapid intervention.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.

Purulent pericarditis, while rare, remains a potentially fatal complication that requires prompt recognition and management, particularly in patients with a history of intravenous drug use.

Tenecteplase administered up to 24 hours after stroke onset improved functional outcomes in patients with large-vessel occlusion and salvageable brain tissue who lacked access to immediate thrombectomy.

Despite its theoretical benefits, IV albumin has not shown consistent superiority over crystalloid solutions in sepsis management, prompting a reevaluation of fluid resuscitation strategies in critical care settings.